Gomes-da-Silva, N.C.; Xavier-de-Britto, I.; Soares, M.A.G.; Yoshihara, N.M.A.; Ilem Özdemir, D.; Ricci-Junior, E.; Fechine, P.B.A.; Alencar, L.M.R.; Henriques, M.d.G.M.d.O.; Barja-Fidalgo, T.C.;
et al. Nanostructured Lipoxin A4: Understanding Its Biological Behavior and Impact on Alzheimer’s Disease (Proof of Concept). Pharmaceutics 2025, 17, 649.
https://doi.org/10.3390/pharmaceutics17050649
AMA Style
Gomes-da-Silva NC, Xavier-de-Britto I, Soares MAG, Yoshihara NMA, Ilem Özdemir D, Ricci-Junior E, Fechine PBA, Alencar LMR, Henriques MdGMdO, Barja-Fidalgo TC,
et al. Nanostructured Lipoxin A4: Understanding Its Biological Behavior and Impact on Alzheimer’s Disease (Proof of Concept). Pharmaceutics. 2025; 17(5):649.
https://doi.org/10.3390/pharmaceutics17050649
Chicago/Turabian Style
Gomes-da-Silva, Natália Cristina, Isabelle Xavier-de-Britto, Marilia Amável Gomes Soares, Natalia Mayumi Andrade Yoshihara, Derya Ilem Özdemir, Eduardo Ricci-Junior, Pierre BasÃlio Almeida Fechine, Luciana Magalhães Rebelo Alencar, Maria das Graças Muller de Oliveira Henriques, Thereza Christina Barja-Fidalgo,
and et al. 2025. "Nanostructured Lipoxin A4: Understanding Its Biological Behavior and Impact on Alzheimer’s Disease (Proof of Concept)" Pharmaceutics 17, no. 5: 649.
https://doi.org/10.3390/pharmaceutics17050649
APA Style
Gomes-da-Silva, N. C., Xavier-de-Britto, I., Soares, M. A. G., Yoshihara, N. M. A., Ilem Özdemir, D., Ricci-Junior, E., Fechine, P. B. A., Alencar, L. M. R., Henriques, M. d. G. M. d. O., Barja-Fidalgo, T. C., Follmer, C., & Santos-Oliveira, R.
(2025). Nanostructured Lipoxin A4: Understanding Its Biological Behavior and Impact on Alzheimer’s Disease (Proof of Concept). Pharmaceutics, 17(5), 649.
https://doi.org/10.3390/pharmaceutics17050649
